SCHEMBL2811683

SCHEMBL2811683

COc1ccc(CN2CCC3NN(C)c4nc(N5CCCCC5)nc2c43)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
MAPK1 P28482 1/20 0.39
GALR2 O43603 2/20 0.38
HRH3 Q9Y5N1 1/20 0.38
NPY5R Q15761 2/20 0.37
GALR1 P47211 1/20 0.37
BRS3 P32247 1/20 0.37
NOS1 P29475 1/20 0.37
ALDH1A1 P00352 2/20 0.36
EHMT2 Q96KQ7 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
HTR6 P50406 1/20 0.36
GAA P10253 2/20 0.36
ALOX15 P16050 2/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2809519 0.92 HTR6 (0.45) MAPK1ALDH1A1EHMT2KDM4EHPGD
SCHEMBL2809530 0.90 MAPT (0.44) SMN1; SMN2MAPK1ALDH1A1KDM4EHPGD
SCHEMBL2812073 0.89 DNMT3A (0.43) SMN1; SMN2MAPK1GALR2GALR1ALDH1A1
SCHEMBL2810409 0.88 SRC (0.43) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL2810429 0.87 KDM4E (0.44) SMN1; SMN2ALDH1A1EHMT2KDM4EHTR6
SCHEMBL2811753 0.87 EHMT2 (0.42) SMN1; SMN2GALR2GALR1EHMT2NPSR1
SCHEMBL2815921 0.86 TSHR (0.42) SMN1; SMN2MAPK1ALDH1A1KDM4ELMNA
SCHEMBL2813977 0.85 HRH3 (0.44) HRH3ALDH1A1KDM4EGAANPSR1
SCHEMBL2809447 0.85 TSHR (0.37) HRH3KDM4EHTR6LMNATSHR
SCHEMBL537664 0.84 PTGIR (0.39) PTGIRSMN1; SMN2HRH3ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 PTGIR 602/4885SMN1; SMN2 2524/4885MAPK1 1997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.